|
|
Volumn 293, Issue 13, 2005, Pages
|
|
Pharmaceutical industry funding for residencies sparks controversy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
IMIQUIMOD;
DRUG INDUSTRY;
EDUCATION PROGRAM;
FINANCE;
HUMAN;
MEDICAL EDUCATION;
MEDICAL SPECIALIST;
MEDICARE;
PHYSICIAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSORIASIS;
RESIDENCY EDUCATION;
REVIEW;
RHEUMATOID ARTHRITIS;
SALARY;
SKIN DISEASE;
ARTICLE;
CONFLICT OF INTEREST;
DERMATOLOGY;
ECONOMICS;
EDUCATION;
ETHICS;
HEALTH CARE AND PUBLIC HEALTH;
MANPOWER;
UNITED STATES;
HEALTH CARE AND PUBLIC HEALTH;
CONFLICT OF INTEREST;
DERMATOLOGY;
DRUG INDUSTRY;
INTERNSHIP AND RESIDENCY;
TRAINING SUPPORT;
UNITED STATES;
|
|
EID: 15944429023
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.293.13.1572 Document Type: Review |
|
Times cited : (18)
|
|
References (0)
|